Daktari Diagnostics reports $1.2M debt funding

By James Connolly

MIT’s needleless injection draws interest from Sanofi [May 25, 2012]

Spectra rakes in another round of funding [May 25, 2012]

Dynasil partners with Mayo Clinic on two projects [May 24, 2012]

Alere recalls 800,000 heart tests, stock drops [May 23, 2012]

Daktari Diagnostics Inc., a Cambridge biotech developing blood-based diagnostic tools for the developing world, has reported a $1.25 million debt funding, according to a filing with the U.S. Securities and Exchange Commission.

Daktari, founded in 2008, reported that it has sold $1,178,530 so far in the offering. The company had raised at least $5 million in total during three previous equity rounds, most recently in 2010.

Previous investors include Partners Innovation Fund, with additional funding from angel investor groups Launchpad Venture Group, Hub Angels Investment Group and Boston Harbor Angels. Directors listed in the filing include Aaron Sandoski, founder of Norwich Ventures, Roger Kitterman of Partners Research Ventures, Edward Roberts, a professor at the MIT Sloan School of Management, and serial entrepreneur Stanley Lapidus, who has served as CEO of Cytyc, EXACT Sciences. Helicos BioSciences, and, currently, SynapDx Corp.

Comments

If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.